PharmacyChecker Blog

Helping Americans Get The Truth About Prescription Drug Savings
Published by:

Diabetics Out in Full Force to Rock the Big Pharma Boat – #insulin4all

There is profound frustration and anger reverberating throughout the diabetic community due to the skyrocketing prices of insulin in the United States. Pharmaceutical companies like Novo Nordisk, Eli Lilly and Sanofi are charging out-of-reach prices for insulin medications necessary for diabetics’ survival.

On September 9th, 2017, over forty people gathered outside of Eli Lilly headquarters in Indianapolis to make a statement on behalf of American citizens living with diabetes and, in actuality, all Americans who face the highest drug prices in the world.

(more…)

Share
Tagged with: , , , , , ,

Online Pharmacies, Personal Drug Importation, and Public Health: Industry Dominance of “Stakeholders” Consulted by GAO

Continuing our quest to get the truth out and for our elected leaders in Congress to take bold action to protect online access to safe and affordable medication, we’re publishing a section a week of our report called Online Pharmacies, Personal Drug Importation, and Public Health. The Government Accountability Office Report on Internet pharmacies, which we’ve attested contains inaccuracies and is misleading about buying medication online, clearly relied heavily on pharmaceutical industry sources. Here’s how:

Some pharmaceutical companies, including many members of the PhRMA, view foreign online pharmacies as a commercial threat because Americans are able to obtain medications at lower prices leading to lower profits. The U.S. pharmacy industry views non-U.S. online pharmacies as unfair competition because the latter can charge lower prices. Many of the groups identified by GAO as stakeholders are drug companies and U.S. pharmacies or groups that they fund, including the following groups:

  1. Alliance for Safe Online Pharmacies
  2. International AntiCounterfeiting Coalition
  3. National Association of Boards of Pharmacy Pharmacies
  4. National Association of Chain Drug Stores
  5. National Community Pharmacists Association
  6. Partnership for Safe Medicines
  7. Pharmaceutical Security Institute
  8. PhRMA

Of the 35 stakeholder groups identified by GAO, at least 33% (13) are pharmaceutical companies or groups that receive funding by pharmaceutical companies or U.S. pharmacies. Another stakeholder is the Center for Safe Internet Pharmacies (CSIP), as are eight of its member companies. CSIP is a private consortium of businesses formed in response to pressure by the White House Office of the Intellectual Property Enforcement Coordinator, which mostly operates as another voice and information clearinghouse for the other stakeholders listed. Three associations representing U.S. pharmacy boards and pharmacies are listed above.

(more…)

Share
Tagged with: , , , , ,

Online Pharmacies, Personal Drug Importation and Public Health: Section 1127 of FDASIA Was Drafted By a Lobbyist for a Pharmaceutical Industry Funded Group

To see just how drug company lobbyists snake their way into the legislative process please read this next section, which follows the executive summary.

You can view the whole report here.

The GAO inquiry into online pharmacies mandated by FDASIA in its Section 1127 was drafted by a lobbyist in the employ of a government relations firm (FaegreBD Consulting) hired by the Alliance for Safe Online Pharmacies (ASOP), a group that is led by Eli Lilly, the National Association of Chain Drugstores and LegitScript.The executive director of ASOP is Libby Baney, who now runs a consulting firm called FWD Strategies International.1 According to its website, FWD Strategies International “is not just a name; it is what we do – moving your vision forward.” In marketing her firm, Ms. Baney notes that one of its services is drafting congressional legislation. As an example of draft legislation, she notes Section 1127 of FDASIA among others relating to online pharmacy.

As evidenced above, it’s not surprising that Section 1127 did not encourage the GAO to perform serious research and independent analysis about online pharmacy safety. Instead Section 1127 conspicuously calls for GAO to report on “laws, policies, and activities that would educate consumers about how to distinguish pharmacy Internet web sites that comply with Federal and State laws and established industry standards from those pharmacy Internet websites that do not comply with such laws and standards…” That language represents the “vision” of the founders and funders of ASOP, companies and people with a history of working to curtail access by Americans to lower cost medication from safe international online pharmacies.2


1 Libby Baney is identified as a lobbyist for the Alliance for Safe Online Pharmacies in this lobbying disclosure report: http://soprweb.senate.gov/index.cfm?event=getFilingDetails&filingID=6B1B406C-D5C0-48C6-9484-B9FF3B372B1F&filingTypeID=51 [Last accessed 10/21/2014].

2 Some of ASOP’s funders seek extreme actions, such as “delisting,” to achieve their goals. Eli Lilly recommends that search engines remove organic results so that Americans can no longer find online pharmacies that are not based in the U.S. See, testimony by Bruce Longbottom, JD, Eli Lilly, Statement to the House Energy and Commerce Committee, Subcommittee on Oversight and Investigations, February 27th, 2014, see http://docs.house.gov/meetings/IF/IF02/20140227/101804/HHRG-113-IF02-Wstate-LongbottomB-20140227.pdf [Last accessed 10/24/2014]. View the actual testimony about delisting here.

Share
Tagged with: , , ,